{"filing":{"accession_number":"0001140361-26-026169","cik":"0001339005","ticker":"FEMY","company_name":"FEMASYS INC","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"ef20076706_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1339005/000114036126026169/ef20076706_8k.htm"},"events":[{"id":13421,"run_id":11919,"accession_number":"0001140361-26-026169","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The filing discloses that Femasys has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a minimum bid price deficiency notice issued on July 16, 2025. While the company has now cured the deficiency through a 1-for-20 reverse stock split completed June 5, 2026, the core event is the resolution of a delisting risk that previously threatened the company's continued listing on Nasdaq. This is material to investors as it directly affects the company's ability to remain publicly traded.","company_name":"FEMASYS INC","ticker":"FEMY","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10558,"accession_number":"0001140361-26-026169","item_number":"8.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Femasys has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a minimum bid price deficiency notice issued on July 16, 2025. While the company has now cured the deficiency through a 1-for-20 reverse stock split completed June 5, 2026, the core event is the resolution of a delisting risk that previously threatened the company's continued listing on Nasdaq. This is material to investors as it directly affects the company's ability to remain publicly traded.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T13:36:38.022057+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10558,"accession_number":"0001140361-26-026169","item_number":"8.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that Femasys has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a minimum bid price deficiency notice issued on July 16, 2025. While the company has now cured the deficiency through a 1-for-20 reverse stock split completed June 5, 2026, the core event is the resolution of a delisting risk that previously threatened the company's continued listing on Nasdaq. This is material to investors as it directly affects the company's ability to remain publicly traded.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T13:36:38.022057+00:00","company_name":"FEMASYS INC","ticker":"FEMY","filing_date":"2026-06-24"}]}